These data highlight the need for vigilance and preparedness if further human transmission occurs. Clinical illness resulting from HPAI A(H5N1) infection can range from mild symptoms like conjunctivitis and upper respiratory issues to severe or critical conditions such as pneumonia, multi-organ failure, and sepsis. Mortality rates in humans are alarmingly high, making it a serious public health concern.

To address this threat, this new webinar will focus on several fronts. First, Dr. Bornstein will discuss surveillance and monitoring of individuals exposed to infected animals (cows, birds, or other domestic/wild species). Second, there will be a discussion about what testing is available for symptomatic individuals. Third, there will be a discussion concerning virus replication in human and cow cells and assessing its severity and transmissibility. Finally, there will be an update on available vaccines and cross-reactive vaccines.

In this informative new webinar, Dr. Bornstein will delve into the critical aspects of Avian Influenza, emphasizing its clinical implications and potential solutions. He will discuss surveillance strategies, diagnostic approaches, and the importance of cross-sector collaboration. For medical professionals, correct information, vigilance, and preparedness play a pivotal role in mitigating the impact of this zoonotic threat.